相关实验视频
Updated: Jul 12, 2025

11:42
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
9.5K
细胞癌的转移模式受到组织学亚型,等级和类细胞分化的影响
1Department of Pathology, Chungnam National University School of Medicine, Daejeon 35015, Republic of Korea.
Medicina (Kaunas, Lithuania)
|October 28, 2023
概括
组织学亚型,核等级和类分化显著预测细胞癌 (RCC) 的转移. 了解这些因素可以更好地预测癌症的传播和患者治疗结果.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 转移是细胞癌 (RCC) 患者的主要死亡原因.
- 预测转移对于有效的RCC患者管理至关重要.
- 了解转移模式有助于制定有针对性的治疗策略.
研究的目的:
- 为了确定RCC的组织学亚型,核等级和瘤分化是否能预测转移的概率和位置.
- 分析跨清细胞,乳头细胞和染色恐惧RCC亚型的转移模式.
- 为了评估 sarcomatoid分化对RCC转移的影响.
主要方法:
- 从监测,流行病学和最终结果 (SEER) 数据库中分析RCC病例.
- 包括清细胞,乳头细胞,染色体恐惧症和类RCC组织学亚型.
- 基于组织学亚型,核等级和类特征的转移模式的统计比较.
主要成果:
- 清细胞RCC显示大脑和肺转移的比率更高.
- 乳头RCC与较少的骨转移,但更多的淋巴结转移有关.
- 染色恐惧性RCC表现出更高的肝转移的可能性.
- 增加的核级与清细胞RCC中较大的肺转移相关.
- 类RCC的总体转移率更高,特别是在骨和肺部.
结论:
- 组织学亚型是RCC转移位置的重要预测因素.
- 核级和类分化是影响RCC转移潜力的重要因素.
- 这些发现提高了预测和管理RCC转移的能力.
更多相关视频
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
9.0K
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.6K
相关概念视频
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K